Credit Suisse Ag Cerus Corp Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.5 - $3.07 $11,686 - $23,918	-7,791 Reduced 2.78%	272,394 $441,000
Q2 2023 Aug 11, 2023	BUY	$1.79 - $2.9 $13,806 - $22,367	7,713 Added 2.83%	280,185 $689,000
Q1 2023 May 10, 2023	BUY	$2.65 - $3.81 $47,927 - $68,907	18,086 Added 7.11%	272,472 $809,000
Q4 2022 Feb 13, 2023	BUY	$3.38 - $4.22 $156,426 - $195,301	46,280 Added 22.24%	254,386 $928,000
Q3 2022 Nov 10, 2022	BUY	$3.43 - $5.83 $54,255 - $92,218	15,818 Added 8.23%	208,106 $750,000
Q2 2022 Aug 12, 2022	SELL	$4.41 - $5.69 $18,883 - $24,364	-4,282 Reduced 2.18%	192,288 $1.02 Million
Q1 2022 May 16, 2022	BUY	$4.81 - $6.99 $93,035 - $135,200	19,342 Added 10.91%	196,570 $1.08 Million
Q4 2021 Feb 14, 2022	SELL	$5.97 - $7.93 $105,489 - $140,123	-17,670 Reduced 9.07%	177,228 $1.21 Million
Q3 2021 Nov 12, 2021	BUY	$4.79 - $6.68 $71,404 - $99,578	14,907 Added 8.28%	194,898 $1.19 Million
Q2 2021 Aug 16, 2021	BUY	$5.35 - $6.35 $160,200 - $190,144	29,944 Added 19.96%	179,991 $1.06 Million
Q1 2021 May 14, 2021	SELL	$5.68 - $7.87 $252,192 - $349,428	-44,400 Reduced 22.83%	150,047 $901,000
Q4 2020 Feb 12, 2021	BUY	$5.25 - $8.56 $345,812 - $563,838	65,869 Added 51.23%	194,447 $1.35 Million
Q3 2020 Nov 13, 2020	SELL	$5.78 - $7.47 $64,481 - $83,335	-11,156 Reduced 7.98%	128,578 $805,000
Q2 2020 Aug 12, 2020	BUY	$4.5 - $7.02 $284,616 - $444,000	63,248 Added 82.69%	139,734 $922,000
Q1 2020 May 13, 2020	BUY	$2.87 - $5.49 $12,122 - $23,189	4,224 Added 5.85%	76,486 $356,000
Q4 2019 Feb 12, 2020	SELL	$3.84 - $4.86 $35,631 - $45,095	-9,279 Reduced 11.38%	72,262 $305,000
Q3 2019 Nov 12, 2019	BUY	$4.86 - $6.05 $41,222 - $51,316	8,482 Added 11.61%	81,541 $420,000
Q2 2019 Aug 14, 2019	SELL	$4.51 - $6.6 $67,731 - $99,118	-15,018 Reduced 17.05%	73,059 $411,000
Q1 2019 May 14, 2019	BUY	$5.16 - $6.85 $97,498 - $129,430	18,895 Added 27.31%	88,077 $548,000
Q4 2018 Feb 13, 2019	SELL	$4.89 - $7.16 $91,291 - $133,670	-18,669 Reduced 21.25%	69,182 $350,000
Q3 2018 Nov 13, 2018	BUY	$6.89 - $7.78 $41,794 - $47,193	6,066 Added 7.42%	87,851 $633,000
Q2 2018 Aug 14, 2018	SELL	$5.19 - $7.25 $81,384 - $113,687	-15,681 Reduced 16.09%	81,785 $545,000
Q1 2018 May 15, 2018	BUY	$3.56 - $5.74 $143,136 - $230,788	40,207 Added 70.22%	97,466 $534,000
Q4 2017 Feb 14, 2018	SELL	$2.76 - $3.95 $247,097 - $353,635	-89,528 Reduced 60.99%	57,259 $193,000
Q3 2017 Nov 14, 2017	BUY	$2.22 - $2.73 $205,307 - $252,473	92,481 Added 170.3%	146,787 $400,000
Q2 2017 Aug 14, 2017	BUY	N/A	54,306	54,306 $137,000

Others Institutions Holding CERS

# of Institutions

157

Shares Held

148M

Call Options Held

84.2K

Put Options Held

55.5K

Baker Bros. Advisors LP New York, NY

19.5M
Shares

$35.3 Million
0.36% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

18.2M
Shares

$33 Million
0.3% of portfolio
Black Rock Inc. New York, NY

13.9M
Shares

$25.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.8M
Shares

$19.6 Million
0.0% of portfolio
Primecap Management CO Pasadena, CA

8.54M
Shares

$15.5 Million
0.01% of portfolio

View Full List

About CERUS CORP

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $321M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

More about CERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account